Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipid Technologies Provider
Swedenlipidlab.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company developed Olibra, a patented combination of oat and palm oils shown in studies to reduce calorie intake by improving satiety. At the time of acquisition by DSM, research was ongoing into new weight management products using this technology. The ingredient has been commercialized globally under various brands including Fabuless. New applications outside weight management were also being explored at the time of acquisition
- Therapeutic areas
- Metabolic DisordersEndocrinology
- Modalities
- Small molecule (lipids and lipid-based formulations)Nutritional ingredient (functional food additive)Delivery system (lipid-based delivery technology)
- Industry
- Food & Nutrition
02
Partnerships
DSM had exclusive global sales/marketing rights to Olibra for dairy foods prior to full acquisition; no other major partnerships listed
Beyond the preview
Go deeper on Lipid Technologies Provider.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipid Technologies Provider.